glp 1 research GLP-1 Agonists Market Exclusive Report 2025 How RWD is transforming GLP-1

Postu (Bioinformatic, Munich, Germany) for the algorithms required for the data evaluation

Zhao, H

doi: 10.1016/j.bcp.2023.115852, PMID: [DOI] [PubMed] [Google Scholar] 111

12,13 Regulatory approval for the first GLP-1 RA drug for the treatment of T2D was issued in 2005 and since then GLP-1 RAs have proved highly clinically effective

The findings in this study should be pursued further." Etminan also acknowledged the studys limitations

The development of GLP-/GIP dual agonists provides a more complete scheme for the treatment of metabolic diseases, but the safety of more dual agonists or multiple agonists in clinical trials is also worthy of attention